Reformulated imatinib eliminates morphine tolerance in lab studies
By reformulating the common cancer drug imatinib (Gleevec), researchers have eliminated morphine tolerance in rats – an important step toward improving the effectiveness of chronic pain management in patients, according ...
Medications
Feb 21, 2012 |
4.8 / 5 (5) |
3
|
To prevent leukemia's dreaded return, go for the stem cells
Researchers reporting in the April Cell Stem Cell, a Cell Press publication, have found a way to stop leukemia stem cells in their tracks. The advance in mice suggests that a combination approach to therapy might stamp out ch ...
Cancer
Apr 05, 2012 |
4.7 / 5 (3) |
0
Toward a more efficient therapy for a specific form of leukemia
Chronic myeloid leukemia (CML) is a particular form of leukemia or cancer of the bone marrow, which can be treated with targeted imatinib. However, in some cases this medicine has no effect. Researchers at the VIB Vesalius ...
Cancer
Jun 14, 2011 |
5 / 5 (1) |
0
Scientists discover how to beat resistance to standard leukaemia drug
(Medical Xpress) -- Cancer Research UK-funded scientists at The Institute of Cancer Research (ICR) have revealed a technique to kill chronic myeloid leukaemia (CML) cells that have stopped responding to a targeted drug, according ...
Cancer
Dec 09, 2011 |
5 / 5 (1) |
0
Targeted drug helps leukemia patients who do not benefit from initial therapy
A new study has found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience long-term benefits when they switch to the targeted drug imatinib. Published early online ...
Cancer
Feb 27, 2012 |
5 / 5 (1) |
0
Cancer drug a possible treatment for multiple sclerosis
(Medical Xpress)—A drug that is currently used for cancer can relieve and slow down the progression of the autoimmune disease multiple sclerosis (MS) in rats, according to a new study published in PLOS ONE. The discovery, which ...
Medical research
Feb 21, 2013 |
4 / 5 (1) |
0
|
